These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 25906289)

  • 21. Urine antibody against human cancer antigen NY-ESO-1.
    Jäger D; Stockert E; Karbach J; Herrlinger K; Atmaca A; Arand M; Chen YT; Gnjatic S; Old LJ; Knuth A; Jäger E
    Cancer Immun; 2002 Aug; 2():10. PubMed ID: 12747755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An expression of squamous cell carcinoma antigen 2 in peripheral blood within the different stages of esophageal carcinogenesis.
    Yang YF; Li H; Xu XQ; Diao YT; Fang XQ; Wang Y; Zhao DL; Wu K; Li HQ
    Dis Esophagus; 2008; 21(5):395-401. PubMed ID: 19125792
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Automated immunoassay of serum NY-ESO-1 and XAGE1 antibodies for predicting clinical benefit with immune checkpoint inhibitor (ICI) in advanced non-small cell lung cancer.
    Sakaeda K; Kurose K; Matsumura Y; Muto S; Fukuda M; Sugasaki N; Fukuda M; Takemoto S; Taniguchi H; Masuda T; Shimizu K; Kataoka Y; Irino Y; Sakai Y; Atarashi Y; Yanagida M; Hattori N; Mukae H; Nakata M; Kanda E; Oga T; Suzuki H; Oka M
    Cancer Treat Res Commun; 2024; 40():100830. PubMed ID: 38964205
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of MAGE-A and NY-ESO-1 in Primary and Metastatic Cancers.
    Park TS; Groh EM; Patel K; Kerkar SP; Lee CC; Rosenberg SA
    J Immunother; 2016 Jan; 39(1):1-7. PubMed ID: 26641256
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dose-dependent effects of NY-ESO-1 protein vaccine complexed with cholesteryl pullulan (CHP-NY-ESO-1) on immune responses and survival benefits of esophageal cancer patients.
    Kageyama S; Wada H; Muro K; Niwa Y; Ueda S; Miyata H; Takiguchi S; Sugino SH; Miyahara Y; Ikeda H; Imai N; Sato E; Yamada T; Osako M; Ohnishi M; Harada N; Hishida T; Doki Y; Shiku H
    J Transl Med; 2013 Oct; 11():246. PubMed ID: 24093426
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Six autoantibodies as potential serum biomarkers of hepatocellular carcinoma: A prospective multicenter study.
    Okada R; Otsuka Y; Wakabayashi T; Shinoda M; Aoki T; Murakami M; Arizumi S; Yamamoto M; Aramaki O; Takayama T; Wakiyama S; Yanaga K; Amikura K; Kaneko H; Shimada H
    Int J Cancer; 2020 Nov; 147(9):2578-2586. PubMed ID: 32574375
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multipanel assay of 17 tumor-associated antibodies for serological detection of stage 0/I breast cancer.
    Sumazaki M; Ogata H; Nabeya Y; Kuwajima A; Hiwasa T; Shimada H
    Cancer Sci; 2021 May; 112(5):1955-1962. PubMed ID: 33605508
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effectiveness of serum midkine in detecting esophageal squamous cell carcinoma.
    Shiratori F; Ito M; Yajima S; Suzuki T; Oshima Y; Nanami T; Funahashi K; Shimada H
    Esophagus; 2019 Jul; 16(3):246-251. PubMed ID: 30778774
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Analysis of CT antigen expression and humoral immunogenicity of NY-ESO-1 protein in gastric carcinoma].
    Wu XJ; Wang Y; Ji JF
    Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Jun; 37(3):252-6. PubMed ID: 15968313
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined detection of serum autoantibodies as diagnostic biomarkers in esophagogastric junction adenocarcinoma.
    Xu YW; Chen H; Guo HP; Yang SH; Luo YH; Liu CT; Huang XY; Tang XM; Hong CQ; Li EM; Xu LY; Peng YH
    Gastric Cancer; 2019 May; 22(3):546-557. PubMed ID: 30426295
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor-associated autoantibodies against Fascin as a novel diagnostic biomarker for esophageal squamous cell carcinoma.
    Chen WX; Hong XB; Hong CQ; Liu M; Li L; Huang LS; Xu LY; Xu YW; Peng YH; Li EM
    Clin Res Hepatol Gastroenterol; 2017 Jun; 41(3):327-332. PubMed ID: 27956255
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New Assay System Elecsys Anti-p53 to Detect Serum Anti-p53 Antibodies in Esophageal Cancer Patients and Colorectal Cancer Patients: Multi-institutional Study.
    Yajima S; Suzuki T; Oshima Y; Shiratori F; Funahashi K; Kawai S; Nanki T; Muraoka S; Urita Y; Saida Y; Okazumi S; Kitagawa Y; Hirata Y; Hasegawa H; Okabayashi K; Murakami M; Yamashita T; Kato R; Matsubara H; Murakami K; Nakajima Y; Sugita H; Klammer M; Shimada H
    Ann Surg Oncol; 2021 Jul; 28(7):4007-4015. PubMed ID: 33210269
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cancer/testis antigen expression and autologous humoral immunity to NY-ESO-1 in gastric cancer.
    Wang Y; Wu XJ; Zhao AL; Yuan YH; Chen YT; Jungbluth AA; Gnjatic S; Santiago D; Ritter G; Chen WF; Old LJ; Ji JF
    Cancer Immun; 2004 Nov; 4():11. PubMed ID: 15516106
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NY-ESO-1 mRNA expression and immunogenicity in advanced prostate cancer.
    Nakada T; Noguchi Y; Satoh S; Ono T; Saika T; Kurashige T; Gnjatic S; Ritter G; Chen YT; Stockert E; Nasu Y; Tsushima T; Kumon H; Old LJ; Nakayama E
    Cancer Immun; 2003 Jul; 3():10. PubMed ID: 12889868
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictive and prognostic effect of CD133 and cancer-testis antigens in stage Ib-IIIA non-small cell lung cancer.
    Su C; Xu Y; Li X; Ren S; Zhao C; Hou L; Ye Z; Zhou C
    Int J Clin Exp Pathol; 2015; 8(5):5509-18. PubMed ID: 26191258
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Expression of NY-ESO-1 gene in human esophageal carcinoma and its cloning].
    Peng LP; Liu HY; Ran YL; Sun LX; Yu L; Yang ZH
    Ai Zheng; 2002 May; 21(5):469-72. PubMed ID: 12452034
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MAGE-A is More Highly Expressed Than NY-ESO-1 in a Systematic Immunohistochemical Analysis of 3668 Cases.
    Kerkar SP; Wang ZF; Lasota J; Park T; Patel K; Groh E; Rosenberg SA; Miettinen MM
    J Immunother; 2016 May; 39(4):181-7. PubMed ID: 27070449
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic and therapeutic relevance of NY-ESO-1 expression in oral squamous cell carcinoma.
    Ries J; Mollaoglu N; Vairaktaris E; Neukam FW; Nkenke E
    Anticancer Res; 2009 Dec; 29(12):5125-30. PubMed ID: 20044626
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mini-array of multiple tumor-associated antigens (TAAs) in the immunodiagnosis of esophageal cancer.
    Qin JJ; Wang XR; Wang P; Ren PF; Shi JX; Zhang HF; Xia JF; Wang KJ; Song CH; Dai LP; Zhang JY
    Asian Pac J Cancer Prev; 2014; 15(6):2635-40. PubMed ID: 24761876
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating autoantibody to CD25 may be a potential biomarker for early diagnosis of esophageal squamous cell carcinoma.
    Guan S; Liu B; Zhang C; Lee KH; Sun S; Wei J
    Clin Transl Oncol; 2013 Oct; 15(10):825-9. PubMed ID: 23423807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.